Pharmalogic Salt Lake City, LLCFebruary 24, 2026

FDA 483 - Pharmalogic Salt Lake City, LLC - February 24, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmalogic Salt Lake City, LLC

Record Details

Pharmalogic Salt Lake City, LLC, a PET Drug Manufacturer, was cited for failing to take appropriate action to prevent the recurrence of quality problems. The inspection revealed multiple instances of operator error in QC analytical chromatography testing for finished drug products, where awareness training proved inadequate in preventing repeat incidents. This indicates a systemic issue in their quality system's corrective action effectiveness.

Company: Pharmalogic Salt Lake City, LLC
Inspection Date: February 24, 2026
Product Type: Drugs
Office: FDA District Office — Denver, Colorado
People: Joey V. Quitania (Public Affairs Specialist)
Lillian S. Wu
Matthew R. Clabeaux

Open in Dashboard

ID · 26288766-8664-471a-8f87-8ccbc8606913